Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope

Journal of Cereal Science

Volumn 70, Issue , 2016, Pages 47-56

  Heil, Andreas ^a   Ohsam, Jürgen ^a   Büchold, Christian ^a   Pasternack, Ralf ^a   Yokoyama, Keiichi ^b   Kumazawa, Yoshiyuki ^b   Hils, Martin ^a  

^a ZEDIRA GMBH   (Germany)

^b AJINOMOTO CO INC   (Japan)

Author keywords

Celiac disease; Deamidation; Microbial transglutaminase; Tissue transglutaminase

Indexed keywords

EID: 84971222585     PISSN: 07335210     EISSN: 10959963     Source Type: Journal    
DOI: 10.1016/j.jcs.2016.05.022     Document Type: Article

References (24)

1. Arentz-Hansen H., Korner R., Molberg O., Quarsten H., Vader W., Kooy Y.M.C., Lundin K.E.A., Koning F., Roepstorff P., Sollid L.M., McAdam S.N. The intestinal T cell response to -gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J. Exp. Med. 2000, 191:603-612.
2. Bundesinstitut für Risikobewertung, Risikobewertung Transglutaminase in Fleischerzeugnissen 2011, 52:1-6.
3. Cabrera-Chávez F., Rouzaud-Sández O., Sotelo-Cruz N., Calderón de la Barca A.M. Transglutaminase treatment of wheat and maize prolamins of bread increases the serum IgA reactivity of celiac disease patients. J. Agric. Food Chem. 2008, 56:1387-1391.
4. Dekking E.H.A., Van Veelen P.A., de Ru A., Kooy-Winkelaar E.M.C., Gröneveld T., Nieuwenhuizen W.F., Koning F. Microbial transglutaminases generate T cell stimulatory epitopes involved in celiac disease. J. Cereal Sci. 2008, 47:339-346.
5. Dieterich W., Ehnis T., Bauer M., Donner P., Volta U., Riecken E.O., Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 1997, 3:797-801.
6. DZG Aufstellung Glutenfreier Lebensmittel 2015 2015, Deutsche Zöliakie Gesellschaft.
7. Elli L., Roncoroni L., Hils M., Pasternack R., Barisani D., Terrani C., Vaira V., Ferrero S., Bardella M.T. Immunological effects of transglutaminase-treated gluten in coeliac disease. Hum. Immunol. 2012, 73:992-997.
8. Fleckenstein B., Molberg Ø., Qiao S.-W., Schmid D.G., von der Mülbe F., Elgstøen K., Jung G., Sollid L.M. Gliadin T cell epitope selection by tissue transglutaminase in celiac disease. Role of enzyme specificity and pH influence on the transamidation versus deamidation process. J. Biol. Chem. 2002, 277:34109-34116.
9. Gerrard J.A., Sutton K.H. Addition of transglutaminase to cereal products may generate the epitope responsible for coeliac disease. Trends Food Sci. Technol. 2005, 16:510-512.
10. Gianfrani C., Siciliano R.A., Facchiano A.M., Camarca A., Mazzeo M.F., Costantini S., Salvati V.M., Maurano F., Mazzarella G., Iaquinto G., Bergamo P., Rossi M. Transamidation of wheat flour inhibits the response to gliadin of intestinal T cells in celiac disease. Gastroenterology 2007, 133:780-789.
11. Kieliszek M., Misiewicz A. Microbial transglutaminase and its application in the food industry. A review. Folia Microbiol. (Praha) 2014, 59:241-250.
12. Lerner A., Matthias T. Food industrial microbial transglutaminase in celiac disease: treat or trick. Int. J. Celiac Dis. 2016, 3:1-6.
13. Lerner A., Matthias T. Possible association between celiac disease and bacterial transglutaminase in food processing: a hypothesis. Nutr. Rev. 2015, 73:544-552.
14. Lombardi E., Bergamo P., Maurano F., Bozzella G., Luongo D., Mazzarella G., Rotondi Aufiero V., Iaquinto G., Rossi M. Selective inhibition of the gliadin-specific, cell-mediated immune response by transamidation with microbial transglutaminase. J. Leukoc. Biol. 2013, 93:479-488.
15. Molberg Ø., Mcadam S.N., Körner R., Quarsten H., Kristiansen C., Madsen L., Fugger L., Scott H., Norén O., Roepstorff P., Lundin K.E.A., Sjöström H., Sollid L.M. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat. Med. 1998, 4:713-717.
16. Ruh T., Ohsam J., Pasternack R., Yokoyama K., Kumazawa Y., Hils M. Microbial transglutaminase treatment in pasta-production does not affect the immunoreactivity of gliadin with celiac disease patients' sera. J. Agric. Food Chem. 2014, 62:7604-7611.
17. Schuppan D., Junker Y. Turning swords into plowshares: transglutaminase to detoxify gluten. Gastroenterology 2007, 133:1025-1028.
18. Shan L., Molberg Ø., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 2002, 297:2275-2279.
19. Skovbjerg H., Koch C., Anthonsen D., Sjöström H. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease. Biochim. Biophys. Acta 2004, 1690:220-230.
20. Skovbjerg H., Norén O., Anthonsen D., Moller J., Sjöström H. Coeliac disease gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease. Scand. J. Gastroenterol. 2002, 37:812-817.
21. Sollid L.M., Qiao S.-W., Anderson R.P., Gianfrani C., Koning F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 2012, 64:455-460.
22. Stamnaes J., Fleckenstein B., Sollid L.M. The propensity for deamidation and transamidation of peptides by transglutaminase 2 is dependent on substrate affinity and reaction conditions. Biochim. Biophys. Acta 2008, 1784:1804-1811.
23. Vader L.W. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J. Exp. Med. 2002, 195:643-649.
24. Yokoyama K., Nio N., Kikuchi Y. Properties and applications of microbial transglutaminase. Appl. Microbiol. Biotechnol. 2004, 64:447-454.